Cardiff Oncology Stock Technical Analysis

CRDF Stock  USD 2.34  0.08  3.54%   
As of the 26th of June, Cardiff Oncology shows the Standard Deviation of 5.07, risk adjusted performance of (0.13), and Mean Deviation of 3.5. Cardiff Oncology technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cardiff Oncology information ratio, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Cardiff Oncology is priced correctly, providing market reflects its regular price of 2.34 per share. Please also double-check Cardiff Oncology jensen alpha, which is currently at (1.13) to validate the company can sustain itself at a future point.

Cardiff Oncology Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cardiff, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Cardiff
  
Cardiff Oncology's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Cardiff Oncology Analyst Consensus

Target PriceAdvice# of Analysts
7.33Strong Buy4Odds
Cardiff Oncology current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Cardiff analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cardiff stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cardiff Oncology, talking to its executives and customers, or listening to Cardiff conference calls.
Cardiff Analyst Advice Details
Cardiff Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cardiff Oncology technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cardiff Oncology trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Cardiff Oncology Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Cardiff Oncology volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Cardiff Oncology Trend Analysis

Use this graph to draw trend lines for Cardiff Oncology. You can use it to identify possible trend reversals for Cardiff Oncology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Cardiff Oncology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Cardiff Oncology Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Cardiff Oncology applied against its price change over selected period. The best fit line has a slop of   0.06  , which may suggest that Cardiff Oncology market price will keep on failing further. It has 122 observation points and a regression sum of squares at 115.97, which is the sum of squared deviations for the predicted Cardiff Oncology price change compared to its average price change.

About Cardiff Oncology Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cardiff Oncology on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cardiff Oncology based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cardiff Oncology price pattern first instead of the macroeconomic environment surrounding Cardiff Oncology. By analyzing Cardiff Oncology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cardiff Oncology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cardiff Oncology specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2022 2023 2024 (projected)
Graham Number7.596.875.715.42
Receivables Turnover0.670.51.691.61

Cardiff Oncology June 26, 2024 Technical Indicators

Most technical analysis of Cardiff help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cardiff from various momentum indicators to cycle indicators. When you analyze Cardiff charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Cardiff Oncology June 26, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Cardiff stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for Cardiff Stock analysis

When running Cardiff Oncology's price analysis, check to measure Cardiff Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardiff Oncology is operating at the current time. Most of Cardiff Oncology's value examination focuses on studying past and present price action to predict the probability of Cardiff Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardiff Oncology's price. Additionally, you may evaluate how the addition of Cardiff Oncology to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios